Steven W. King
2014
In 2014, Steven W. King earned a total compensation of $1.6M as President and Chief Executive Officer at Peregrine Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Bonus | $111,540 |
|---|---|
| Non-Equity Incentive Plan | $289,112 |
| Option Awards | $472,560 |
| Salary | $446,160 |
| Stock Awards | $139,000 |
| Other | $120,968 |
| Total | $1,579,340 |
King received $472.6K in option awards, accounting for 30% of the total pay in 2014.
King also received $111.5K in bonus, $289.1K in non-equity incentive plan, $446.2K in salary, $139K in stock awards and $121K in other compensation.
Rankings
In 2014, Steven W. King's compensation ranked 5,527th out of 13,032 executives tracked by ExecPay. In other words, King earned more than 57.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,527 out of 13,032 | 58th |
Division Manufacturing | 1,979 out of 4,966 | 60th |
Major group Chemicals And Allied Products | 670 out of 1,686 | 60th |
Industry group Drugs | 519 out of 1,365 | 62nd |
Industry Pharmaceutical Preparations | 406 out of 1,043 | 61st |
Source: SEC filing on August 28, 2014.
King's colleagues
We found five more compensation records of executives who worked with Steven W. King at Peregrine Pharmaceuticals in 2014.
2014
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2014
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2014
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
2014
Shelley Fussey
Peregrine Pharmaceuticals
Vice President, Intellectual Property
2014
Joseph Shan
Peregrine Pharmaceuticals